-
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
By John M. Kane, Christoph U. Correll, Grace S. Liang, Joshua Burke, Christopher F. O’Brien
-
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
By Christoph U. Correll, Richard C. Josiassen, Grace S. Liang, Joshua Burke, Christopher F. O’Brien
-
This product is the full issue of Psychopharmacology Bulletin VOL 47 No. 1. Upon purchase, you will receive a single downloadable PDF file with all this issues articles stacked from front cover to back cover. -
Evidence-Based MedicineTreatment of Autism Spectrum Disorder in Children and Adolescents
By Melissa DeFilippis, Karen Dineen Wagner
-
New Strategies for the Treatment of Indolent Non-Hodgkin’s Lymphomas
By Blanche H. Mavromatis, MD, and Bruce D. Cheson, MD
-
EVIDENCE-BASED MEDICINE
A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders
By Patricia Berney, Demian Halperin, Rodrigo Tango, Isabelle Daeniker-Dayer, Pierre Schulz
-
ORIGINAL RESEARCHThe Sex Effects Scale: Pilot Validation in a Healthy Population
By Sidney H. Kennedy, Sakina J. Rizvi, Kari Fulton, Janet Ellis, Lena C. Quilty, Lakshmi Ravindran
-
Artículo original
Estudio de validación de la Escala de Salud Personal (ESP) en Lima, Perú
Dra. María Isabel Zapata-Vega, Dr. Juan Enrique Mezzich, Dr. Guido Mazzotti, Dr. Robert De la Grecca, Dr. Jean-Pierre Llanos y Dra. Juana Hernández
-
Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients
Lieuwe de Haan, MD, PhD, Britt Hoogeboom, MD, Nico Beuk, MD, Luuk Wouters, Peter M.A.J. Dingemans, PhD, and Don H. Linszen, MD, PhD
-
Efficacy and Tolerability of Controlled-Release Paroxetine
By Robert N. Golden, MD
